Deep Genomics raises $40 million in Series B round

Ontario Industry Updates
Written By Guest User
Deep Genomics logo.png

Toronto-based Deep Genomics, which has developed a platform that uses deep learning to create therapies, has closed a $40 million Series B round. The round was led by Future Ventures, an investor in Tesla and SpaceX, and was joined by Amplitude Ventures, Magnetic Ventures, Khosla Ventures and True Ventures.

Guest User
Previous

Apply for the Canadian Technology Accelerator - Health Programs
Next

ProteinQure named one of CB Insights' Game Changers for 2020